https://youtube.com/playlist?list=PLBSYD0HP9NeG6zyMpn0jQbwbWvkeGoBoO&si=lYaxhHc_M7XrlfYt

KPV = Lysine–Proline–Valine, a short tripeptide derived from the naturally occurring peptide α-MSH (alpha-melanocyte-stimulating hormone). So, what makes KPV interesting? 👇 🔬 Research has focused on: • Inflammatory pathways — particularly pathways involved in regulating inflammatory signaling • Gut & intestinal research — investigated in preclinical models of intestinal inflammation • Skin & barrier function — studied for potential effects on inflammatory skin responses • Immune signaling — researchers are interested in how KPV may influence inflammatory mediators • Oxidative stress — investigated for potential cellular-protective effects Why is KPV often included in peptide blends? KPV is particularly interesting because researchers are exploring its potential anti-inflammatory and tissue-supporting properties without the broader hormonal effects associated with the parent α-MSH molecule. ⚠️ Important: Most KPV research is preclinical, meaning findings from laboratory and animal studies cannot automatically be assumed to work the same way in humans. KPV is not an FDA-approved treatment. Research use only • Not for human consumption

KLOW 80 — Why Is Everyone Talking About It? KLOW 80 is a peptide blend (MG-DFK) that has been gaining attention in longevity and mitochondrial research. 🧬 Peptides included in the blend: • KPV (Lysine–Proline–Valine) • BPC-157 (Body Protection Compound) • TB-500 (Thymosin Beta-4 fragment) • GHK-Cu (Copper peptide) 🔬 Research areas include: • Mitochondrial function & cellular energy • Cellular repair pathways • Tissue regeneration & recovery signaling • Longevity & healthy-aging pathways • Physical performance & recovery • Neuroprotection & cognitive research • Oxidative stress and inflammation pathways 📚 Why I’m interested: KLOW 80 is especially interesting when looking at the bigger picture of mitochondrial health, cellular resilience, and longevity research—especially because it combines multiple well-studied peptides into one blend. ⚠️ Research Use Only Not for human or veterinary consumption. This information is for educational and research purposes only and is not medical advice. 👇 Have you researched KLOW 80 yet? What are you most interested in learning about—mitochondrial health, longevity, recovery, or brain research?

If you’re going to keep research supplies on hand, I think it makes sense to source them from reputable medical-supply companies rather than random marketplaces. A few sites I like to use/check out: - Vitality Medical - AMSCO Medical - Medex Supply For supplies you use regularly, buying by the case can sometimes be more convenient and cost-effective. 💧 Hospira bacteriostatic water — by the case 💉 Sterile needles/syringes — by the case 🧴 Alcohol prep pads and other basic supplies My biggest advice: pay attention to sourcing and product quality. Check that products are sealed, authentic, within their expiration dates, and coming from a legitimate medical-supply distributor. 💡 Tip: Compare the per-unit price when buying by the case. Sometimes the savings can be significant. Research-use products are not automatically safe or appropriate for human use. Always follow applicable laws and seek appropriate professional guidance for anything involving human administration.

I’ve been thinking about mitochondrial/metabolic protocols and wanted to open up a discussion: Would you run SS-31, MOTS-c, NAD+, AND 5-Amino-1MQ together—or is there a point where stacking them becomes unnecessary? They’re often discussed for overlapping areas like: 🧬 Mitochondrial function ⚡ Cellular energy 🔥 Metabolic health 🧠 Cellular resilience ♻️ NAD+ metabolism But overlapping pathways don’t automatically mean that more = better. SS-31 is being researched for mitochondrial membrane function and protection. MOTS-c is a mitochondrial-derived peptide being studied for metabolic signaling and cellular stress responses. NAD+ is central to cellular energy metabolism and redox processes. 5-Amino-1MQ is an NNMT inhibitor being researched for effects on NAD+ metabolism and metabolic health. That last one is what makes me especially curious. 👀 If 5-Amino-1MQ may influence NAD+ availability/metabolism, does adding it to an NAD+ protocol make sense mechanistically—or could the combination simply be redundant? And if SS-31 + MOTS-c are already targeting mitochondrial pathways, is there a compelling reason to add NAD+ as well? Questions for the group: • Has anyone researched the mechanistic overlap between these four? • Would you personally combine them or run them separately to evaluate effects? • Could cycling rather than stacking make more sense? • Are there known concerns about combining multiple compounds that affect mitochondrial/metabolic pathways? Research discussion only — not medical advice. These compounds are not interchangeable, and human clinical evidence for many of these combinations is limited. I’m much more interested in the science and rationale behind the stack than simply hearing “it works.” 🧪 What do you think—stack, cycle, or simplify?